eural, cognitive, and emotional changes in patients with chronic Depression receiving Cognitive Behavioral Analysis System of Psychotherapy (CBASP) - an f-MRI-supported pilot study

Not Applicable

Suspended

• Conditions: F33.9; Recurrent depressive disorder, unspecified

• Registration Number: DRKS00013069
• Lead Sponsor: Medizinischer Campus Universität Oldenburg Fakultät für Medizin und GesundheitswissenschaftenUniversitätsklinik für Psychiatrie und Psychotherapie Karl-Jaspers-Klinik

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2017-10-02
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Suspended
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

patients with chronic depression who get a CBASP therapy

Exclusion Criteria

patients who are younger than 18, patients who are not consentable, patients who take mood-stabilizer or Lithium, patients with MR-specific contraindication, e.g. pace maker etc.

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<br>Brain activity changes in different brain regions at the beginning and at the end of CBASP (Cognitive Behavioral Analysis System of Psychotherapy) therapy measured by functional magnetic resonance imaging

Secondary Outcome Measures

Name	Time	Method
Score changes of the questionnaires (Beck-Depressions-Inventar, Snaith-Hamilton pleasure scale, Hamilton Depression Scale) at the beginning and at the end of CBASP (Cognitive Behavioral Analysis System of Psychotherapy) therapy